Although ncRNAs have now come into focus with regard to aspirin-mediated inhibitory effects on CRC pathogenesis, systematic studies on the role of ncRNAs in aspirin sensitivity of PIK3CA-mutated CRC are scarce to date. The gene discussed is PIK3CA; the disease is colorectal carcinoma.